Authors: Ganser, A Heil, G Seipelt, G Hofmann, W Fischer, JT Langer, W Brockhaus, W Kolbe, K Ittel, H Brack, N Fuhr, HG Knuth, P Hoffken, K Bergmann, L Hoelzer, D

Citation: A. Ganser et al., Intensive chemotherapy with idarubicin, ara-C, etoposide, and m-AMSA followed by immunotherapy with interleukin-2 for myelodysplastic syndromes and high-risk Acute Myeloid Leukemia (AML), ANN HEMATOL, 79(1), 2000, pp. 30-35